Skip to main content
. 2022 Aug 8;28(9):1840–1847. doi: 10.1038/s41591-022-01935-8

Fig. 2.

Fig. 2

Waterfall plot of responses in patients evaluable for response by RANO-BM criteria in the TUXEDO-1 trial. Blue bars illustrate the radiographic change of maximum brain metastasis size after start of trastuzumab deruxtecan therapy compared to the baseline measurement. Red dotted lines denote thresholds for response and progression by RANO-BM criteria.